iSpecimen (ISPC) Capital Expenditures (2020 - 2026)

iSpecimen's Capital Expenditures history runs 7 years deep, the most recent figure standing at $700000.0 for Q1 2026.

• In Q1 2026, Capital Expenditures changed N/A year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $707865.0 (changed N/A YoY), while the FY2025 annual figure was $454.0, down 98.56% from the prior year.
• Capital Expenditures for Q1 2026 stood at $700000.0, up from -$999546.0 in the prior quarter.
• The five-year high for Capital Expenditures was $1.5 million in Q1 2023, with the low at -$2.7 million in Q3 2023.
• The 5-year median for Capital Expenditures is $388590.5 (2022), against an average of $69037.7.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures soared 353.93% in 2023, then tumbled 12808.79% in 2025.
• iSpecimen's Capital Expenditures stood at -$1.3 million in 2022, then tumbled by 103.33% to -$2.7 million in 2023, then soared by 100.29% to $7865.0 in 2024, then sank by 12808.79% to -$999546.0 in 2025, then surged by 170.03% to $700000.0 in 2026.
• Business Quant data shows ISPC's Capital Expenditures at $700000.0 in Q1 2026, -$999546.0 in Q4 2025, and $999546.0 in Q3 2025.